Labcorp (LH) Competitors $261.83 +1.83 (+0.70%) As of 11:38 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock LH vs. HOLX, HSIC, MEDP, AMN, CAH, CHE, DGX, MCK, TMO, and WSTShould you be buying Labcorp stock or one of its competitors? The main competitors of Labcorp include Hologic (HOLX), Henry Schein (HSIC), Medpace (MEDP), AMN Healthcare Services (AMN), Cardinal Health (CAH), Chemed (CHE), Quest Diagnostics (DGX), McKesson (MCK), Thermo Fisher Scientific (TMO), and West Pharmaceutical Services (WST). These companies are all part of the "medical" sector. Labcorp vs. Its Competitors Hologic Henry Schein Medpace AMN Healthcare Services Cardinal Health Chemed Quest Diagnostics McKesson Thermo Fisher Scientific West Pharmaceutical Services Hologic (NASDAQ:HOLX) and Labcorp (NYSE:LH) are both large-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, dividends, valuation, institutional ownership and media sentiment. Which has more volatility and risk, HOLX or LH? Hologic has a beta of 0.55, indicating that its stock price is 45% less volatile than the S&P 500. Comparatively, Labcorp has a beta of 0.82, indicating that its stock price is 18% less volatile than the S&P 500. Do analysts recommend HOLX or LH? Hologic currently has a consensus target price of $77.42, indicating a potential upside of 19.47%. Labcorp has a consensus target price of $276.08, indicating a potential upside of 5.44%. Given Hologic's higher possible upside, equities research analysts plainly believe Hologic is more favorable than Labcorp.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hologic 0 Sell rating(s) 11 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.41Labcorp 1 Sell rating(s) 2 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 2.79 Do institutionals and insiders have more ownership in HOLX or LH? 94.7% of Hologic shares are held by institutional investors. Comparatively, 95.9% of Labcorp shares are held by institutional investors. 1.9% of Hologic shares are held by company insiders. Comparatively, 0.8% of Labcorp shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Does the media prefer HOLX or LH? In the previous week, Labcorp had 8 more articles in the media than Hologic. MarketBeat recorded 22 mentions for Labcorp and 14 mentions for Hologic. Hologic's average media sentiment score of 1.35 beat Labcorp's score of 1.05 indicating that Hologic is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hologic 12 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Labcorp 15 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is HOLX or LH more profitable? Hologic has a net margin of 13.83% compared to Labcorp's net margin of 5.55%. Hologic's return on equity of 19.71% beat Labcorp's return on equity.Company Net Margins Return on Equity Return on Assets Hologic13.83% 19.71% 10.87% Labcorp 5.55%15.27%6.97% Which has preferable valuation and earnings, HOLX or LH? Hologic has higher earnings, but lower revenue than Labcorp. Hologic is trading at a lower price-to-earnings ratio than Labcorp, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHologic$4.03B3.58$789.50M$2.3727.34Labcorp$13.01B1.68$746M$8.6530.27 SummaryHologic and Labcorp tied by winning 8 of the 16 factors compared between the two stocks. Get Labcorp News Delivered to You Automatically Sign up to receive the latest news and ratings for LH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LH vs. The Competition Export to ExcelMetricLabcorpMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$21.91B$7.32B$5.49B$20.64BDividend Yield1.09%2.77%5.39%3.77%P/E Ratio30.2627.9726.7128.03Price / Sales1.6831.92419.5937.85Price / Cash11.8021.4136.1321.91Price / Book2.726.688.064.59Net Income$746M$233.06M$3.16B$984.95M7 Day Performance1.83%1.89%1.81%2.85%1 Month Performance4.49%4.56%3.99%5.39%1 Year Performance28.29%34.48%35.40%14.47% Labcorp Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LHLabcorp4.3693 of 5 stars$261.83+0.7%$276.08+5.4%+28.3%$21.91B$13.01B30.2670,000Positive NewsInsider TradeHOLXHologic4.7817 of 5 stars$65.16+0.2%$77.42+18.8%-11.2%$14.52B$4.03B27.497,063Positive NewsHSICHenry Schein2.8775 of 5 stars$73.05-0.3%$79.30+8.6%+13.5%$8.89B$12.67B22.8325,000Positive NewsMEDPMedpace4.4676 of 5 stars$313.86+1.0%$344.82+9.9%-19.4%$9.02B$2.16B23.965,900AMNAMN Healthcare Services4.218 of 5 stars$20.73-0.7%$32.08+54.8%-55.8%$793.54M$2.98B-4.792,968News CoverageCAHCardinal Health4.8942 of 5 stars$167.92+0.4%$157.43-6.2%+67.7%$40.08B$226.83B26.2046,500Positive NewsAnalyst RevisionCHEChemed4.9691 of 5 stars$485.18-13.3%$645.00+32.9%-13.0%$7.10B$2.43B23.6315,695Analyst ForecastHigh Trading VolumeDGXQuest Diagnostics4.9405 of 5 stars$179.52+1.0%$185.73+3.5%+29.2%$20.04B$9.87B22.7049,000Positive NewsMCKMcKesson4.723 of 5 stars$732.50+0.9%$696.42-4.9%+20.7%$91.64B$359.05B28.3675,000Positive NewsAnalyst RevisionTMOThermo Fisher Scientific4.9956 of 5 stars$405.83-0.6%$604.05+48.8%-19.9%$153.20B$42.88B23.80125,000Positive NewsWSTWest Pharmaceutical Services4.7618 of 5 stars$218.800.0%$320.00+46.3%-31.4%$15.72B$2.89B34.3510,600 Related Companies and Tools Related Companies HOLX Alternatives HSIC Alternatives MEDP Alternatives AMN Alternatives CAH Alternatives CHE Alternatives DGX Alternatives MCK Alternatives TMO Alternatives WST Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:LH) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Labcorp Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Labcorp With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
